Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Absence of DNA Amplification in Blastocoel Fluid Enhance Conventional Blastocyst Selection and IVF Outcome?

NCT04744844 is registered in ClinicalTrials.gov with Antalya IVF as lead sponsor.

NCT NCT04744844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04744844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Absence of DNA Amplification in Blastocoel Fluid Enhance Conventional Blastocyst Selection and IVF Outcome?
Lead sponsor
Antalya IVF
Phase
Not applicable
Overall status
Terminated
Start date
January 1, 2022
Completion date
January 31, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical pregnancy, embryo implantation